Related Experiment Video
Updated: Feb 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes
Signe Holm Nielsen1, Alan J Mouton2, Kristine Y DeLeon-Pennell3
1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, Denmark; Disease Systems Immunology, Technical University of Denmark, Kgs. Lyngby, Denmark.
Insights
Myocardial infarction (MI) triggers left ventricle (LV) scar formation. This review explores extracellular matrix (ECM) remodeling and biomarkers for predicting MI outcomes.
Area of Science:
- Cardiovascular research
- Cardiac remodeling
- Biomarker discovery
Background:
- Cardiovascular Disease (CVD) is a leading cause of death globally.
- Myocardial infarction (MI) significantly contributes to CVD morbidity and mortality.
- Post-MI healing involves extracellular matrix (ECM) scar formation in the left ventricle (LV).
Purpose of the Study:
- To review left ventricle (LV) extracellular matrix (ECM) remodeling after myocardial infarction (MI).
- To identify and discuss ECM biomarkers for predicting MI outcomes.
- To differentiate between beneficial scar formation and detrimental fibrosis post-MI.
Main Methods:
- Literature review focusing on post-MI cardiac fibrosis and ECM remodeling.
- Analysis of existing research on extracellular matrix (ECM) components and their roles.
- Identification of potential ECM biomarkers associated with MI prognosis.
Main Results:
- Cardiac fibrosis post-MI is complex, involving both structural scarring and detrimental stiffening.
- Distinguishing between adaptive and maladaptive ECM accumulation is crucial.
- Specific ECM biomarkers show potential for predicting adverse LV remodeling and heart failure progression.
Conclusions:
- Understanding LV ECM remodeling post-MI is key to improving patient outcomes.
- ECM biomarkers could offer valuable prognostic information for MI patients.
- Further research into ECM dynamics and biomarker validation is warranted.
Abstract:
Cardiovascular Disease (CVD) is the most common cause of death in industrialized countries, and myocardial infarction (MI) is a major CVD with significant morbidity and mortality. Following MI, the left ventricle (LV) undergoes a wound healing response to ischemia that results in extracellular matrix (ECM) scar formation to replace necrotic myocytes. While ECM accumulation following MI is termed cardiac fibrosis, this is a generic term that does not differentiate between ECM accumulation that occurs in the infarct region to form a scar that is structurally necessary to preserve left ventricle (LV) wall integrity and ECM accumulation that increases LV wall stiffness to exacerbate dilation and stimulate the progression to heart failure. This review focuses on post-MI LV ECM remodeling, targeting the discussion on ECM biomarkers that could be useful for predicting MI outcomes.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Myocarditis I: Introduction

